JKN2301 Placebo: Clinical Trials

1 trial of JKN2301 Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow JKN2301 Placebo: new trials by email Literature Review of JKN2301 Placebo trials Research Report on JKN2301 Placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
JKN2301 Dry Suspension, Oseltamivir Placebo, Oseltamivir - Respiratory Viral Infection
Phase 3RecruitingJoincare Pharmaceutical Group Industry Co., Ltd1772025-11-072026-01-21

Sponsors

Joincare Pharmaceutical Group Industry Co., Ltd (1)

Countries

China (1)